No illness reported after hundreds at North Canaan facility decontaminated
NORTH CANAAN, Conn. (WTNH) — North Canaan town officials say no symptoms or sicknesses have been reported by employees forced through a decontamination process last week.
More than 300 Becton-Dickinson facility personnel had to use decontamination showers and change clothes to go home Thursday after a suspicious package was discovered at their workplace.
Over 300 people 'decontaminated' due to suspicious package incident in North Canaan
The facility is back to operating normally Monday, amid an ongoing law enforcement investigation.
Town officials said normal operations won't affect the investigation, which includes the Federal Bureau of Investigation, Department of Emergency Management and Homeland Security, and local and state agencies.
Since being discovered, the Department of Public Health confirmed the package has tested negative for anthrax, burkholderia species, plague, tularemia, and smallpox. A negative Ricin test was confirmed, along with a Day 2 culture test which resulted in 'no growth.'
Officials said the incident was isolated to the facility and there is no risk to the public or adjacent properties.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Boston Globe
21 hours ago
- Boston Globe
Can free money help people stay off drugs? These programs are trying it.
Nothing stuck until Pagan, a 36-year-old personal caregiver from Revere, learned late last year of engaged in physical exercise, Pagan was rewarded with $5 loaded onto a debit card. Advertisement While modest, the payments were enough to motivate Pagan to keep coming back, week after week, to a program that taught her new strategies for controlling her cravings. 'When you're living on the edge, sometimes you need something — even if it's small — to feel better about yourself and your future," she said. Pagan is among hundreds of people addicted to stimulants in New England who are part of a bold but debated experiment: giving financial rewards to people who abstain from illicit drugs. In cities across the region, treatment providers are embracing the concept of monetary awards as they seek new ways to combat a troubling surge in the use of psychostimulants such as methamphetamine and cocaine. Advertisement The approach is known as Policy makers are banking on the intervention to help address a gaping hole in the substance use treatment system. There are no targeted medications for the estimated 'People have been brainwashed into thinking that depriving people and letting them `hit bottom' is the only way for somebody to get better, and contingency management flies in the face of that,' said Deirdre Calvert, director of the state Department of Public Health's Bureau of Substance Addiction Services. 'Most importantly, it works.' While offering people small rewards for abstinence dates to the 1980s, the approach has been slow to catch on. One of the biggest obstacles has been the moral objection to the idea of paying people to stay off drugs — which, critics argue, they should be doing anyway. Legal concerns have been another barrier. Treatment providers have long worried they could run afoul of Advertisement Yet attitudes began to change a few years ago amid a troubling new reality. Many people were taking cocaine and meth without realizing it was At the same time, states received the So in 2021, Boston Medical Center received a $1.43 million grant from the Massachusetts Department of Public Health to launch Interest in the program has far exceeded expectations. Justin Alves, co-medical director for the START program and a nurse educator with the Advertisement All told, 660 patients with stimulant use disorders have participated in the program since 2021; and more than 50 percent have been people of color, according to Boston Medical Center. Organizers of the program are now looking to tap opioid settlement funds to expand the incentives to $300 to $500 per person per year, consistent with scientific studies showing that larger amounts are more effective in promoting abstinence. 'The $75 was enough to get people to come to group [meetings],' Alves said. 'By the time the $75 ran out, we had nurse-patient relationships with people and that's what has made the program blossom.' Behavioral scientists said the programs are effective in part because the prizes act much like stimulants do — by increasing dopamine levels in the brain. The US Department of Veterans Affairs was Advertisement The concept is also taking hold in Maine, which has been And in Vermont, Some treatment providers are wary of giving prizes that they say patients could then sell or trade for drugs. Yet that hasn't emerged as a problem, say clinicians and researchers. The Howard Center tracks how participants spend the rewards and found they largely use the money to buy food, gas, and other basic items. Rosario Malcolm-Testaverde credits a contingency management program with potentially saving his life. He spent 15 years addicted to crystal methamphetamine, bouncing in and out of hospital emergency departments, before he discovered the Boston Medical Center program. He didn't need the money, yet the weekly prizes gave him an incentive to show up at group meetings. There, he encountered a community of people who understood the powerful pull of crystal meth and its dangerous side effects — including paranoia and auditory hallucinations. Advertisement 'I felt fully recognized as a human being,' said Malcolm-Testaverde, 36. 'And the rewards system helped replace the dopamine hit I would get [from crystal meth].' At noon on a recent Monday, the mood was upbeat as Pagan and a dozen other people in recovery filed into a brightly lit conference room at the Boston Health Care for the Homeless office at 780 Albany St. One by one, members introduced themselves and talked about what they were looking forward to in their lives. An older man named John described the daily challenge of staying sober when, each day, he encountered people using cocaine outside his apartment building in Cambridge's Central Square. Among the last to speak, Pagan proudly announced to the group that she had just received word of a new job opportunity and was brushing up her resume — something she never would have imagined just a couple of years ago, when she was still living on the streets and using drugs. 'Hopefully a door opens because I feel like I'm ready,' Pagan said. In an instant, everyone around the table burst into applause. Chris Serres can be reached at


Newsweek
2 days ago
- Newsweek
FBI Working With India to Disrupt Chinese Fentanyl Network—Kash Patel
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Federal Bureau of Investigation (FBI) Director Kash Patel told podcaster Joe Rogan during a Friday episode that the agency is working with the Indian government to dismantle global fentanyl networks, which he said originate in China. Newsweek has reached out to the FBI's press office, the Indian Government's Ministry of External Affairs, and the Chinese Embassy in Washington for comment via email on Saturday. Why It Matters President Donald Trump has made combating the opioid crisis, particularly the influx of illicitfentanyl, a central focus of his administration's policies. Earlier this year, to address the sources of fentanyl trafficking, Trump imposed tariffs on imports from China, Mexico, and Canada. There are some legitimate medical uses for fentanyl. The opioid crisis has far-reaching impacts across the country. In 2024, the United States witnessed a significant decrease in opioid-related overdose deaths, dropping from 110,037 in 2023 to 80,391 in 2024, according to data from the U.S. Centers for Disease Control and Prevention (CDC). Rogan, host of The Joe Rogan Experience podcast, is one of the most-listened-to media figures, drawing an audience of roughly 11 million listeners. What To Know Patel told Rogan that when he joined the bureau, he launched a "massive enterprise" to target companies in China that manufacture "fentanyl precursors." He said that while China may not produce the drug in its final form, it supplies the key ingredients used to make fentanyl, calling the country the "root of the problem." The U.S.-China Economic and Security Review Commission, which provides recommendations to Congress, stated in an August 2021 finding that "China remains the primary country of origin for illicit fentanyl and fentanyl-related substances trafficked into the United States." Patel said during the interview with Rogan that the country has been shipping the precursors "to places like India—and I'm also doing operations in India—and they're having the Mexican cartels now make this fentanyl down in Mexico." In March, the Chinese government published a white paper laying out its purported efforts to crack down on fentanyl trade and hit back at U.S. criticism as Washington imposed tariffs over the issue. "I literally just got off the phone with the Indian government, I said: 'I need your help. This stuff's coming into your country and then they're moving it from your country because India's not consuming fentanyl...I need you and your help,'" the FBI director told Rogan. He explained the FBI is "working with the heads of their [the Indian] government, law enforcement authorities to say, 'We're going to find these companies that buy it and we're going to shut them down. We're going to sanction them; we're going to arrest them where we can. We're going to indict them in America if we can. We're going to indict them in India if we can.'" He reiterated that "this is a global problem." Patel said the Chinese Communist Party (CCP) isn't partaking in the trade for profitability reasons, but rather, "in my opinion, the CCP have used it as a directed approach because we are their their long-term game is how do I, in my opinion, kneecap the United States of America, our largest adversary?" suggesting that the drug allows them to "take out generations of young men and women." Tensions between Washington and Beijing have been high over a slew of issues, including tariff policies and national security issues. In May, federal authorities arrested 16 individuals and seized over 400 kilograms of the drug in the largest fentanyl bust in Drug Enforcement Administration (DEA) history. FBI Director Kash Patel is seen in Washington on May 8. FBI Director Kash Patel is seen in Washington on May 8. AP Photo/Jose Luis Magana What People Are Saying U.S. Treasury Secretary Scott Bessent told CNBC in mid-May: "I have a personal stake in this. There are two very close friends [who] lost children to this terrible scourge. Hundreds of thousands of Americans die every year. And I think that we saw here in Geneva the Chinese are now serious about assisting the U.S. in stopping the flow of precursor drugs." A spokesperson for the Chinese foreign ministry said in March: "Facts speak louder than words. The U.S. is spreading all kinds of false information on the fentanyl issue, smearing and scapegoating China, and hiking tariffs on Chinese imports over fentanyl." President Donald Trump wrote in an April 24 Truth Social post: "...By the way, Fentanyl continues to pour into our Country from China, through Mexico and Canada, killing hundreds of thousands of our people, and it better stop, NOW!" What Happens Next? It is unclear what the partnership looks like, but according to Patel it is ongoing.
Yahoo
3 days ago
- Yahoo
Botulism cases linked to Botox injections under investigation in Massachusetts
Massachusetts health officials are investigating four recent cases of suspected botulism connected to cosmetic injections of Botox. The outbreak on the South Shore prompted the Department of Public Health to warn health care providers to be alert about symptoms. consistent with botulism occurring after botulinum toxin injections. Botox is widely used for cosmetic purposes to reduce wrinkles and fine lines. 'While generally safe when administered by trained professionals, improper dosing, administration technique, or use of non-FDA-approved products may increase the risk of systemic botulism symptoms,' the DPH advisory said. Botulism, though rare, can be fatal. It occurs when botulinum toxin enters the bloodstream and can produce effects far from the injection site, according to the advisory. Initial botulism symptoms include double or blurred vision, drooping eyelids, slurred speech, difficulty swallowing and breathing problems, according to state health officials. These symptoms may progress to muscle weakness that worsens over hours to days. Anybody who is experiencing any symptoms should go to an emergency room. 'This is very rare,' South Shore Hospital infectious disease specialist Dr. Todd Ellerin told WCVB. 'We call it iatrogenic botulism, which means you get it as a complication of an injection. It is very rare.' The DPH has not released details about the condition of the four individuals involved in the South Shore cases or information about the provider or facility where they received their injections. How pink heart shaped fentanyl led to Mass. father's 18-year prison sentence ICE deportation blocked by Boston judge: Migrants now in shipping container in Djibouti Mass. State Lottery winner: Father will take children to Disney with $100K prize Former police deputy chief, school resource officer convicted of child rape Mass. casino winner: $2.50 bet won gambler jackpot prize ``` Read the original article on MassLive.